Study of Neurological Damage From Coronavirus Disease (COVID-19) (NeuroBiomarK)

University Hospital, Strasbourg, France

Status: Unknown

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT05079373

8184

Details and patient eligibility

About

The objective of this study is to support the exploration of the NEURO-COVID-19 database and in particular to carry out the post-treatments necessary to derive quantitative information on the characterization of the lesion load, in particular with regard to of the vascular tree

Enrollment: 250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patient (≥18 years old)
• COVID + patient presenting with neurological symptoms leading to an MRI.
• Patient taken care of in one of the care centers associated with this research
• Patient not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

• Patient who expressed his opposition to participating in the study
• COVID patient not having neurological symptoms or not having received an MRI
• Patient under guardianship or guardianship
• Patient under legal protection